MRSA Nare Testing in Pediatric Pneumonia Patients,
Role: Investigator,
LLU Dept. of Pediatrics,
(01/2024)
Status: Approved
Impact of 24/7 Pharmacist-driven Interventions of Rapid Diagnostic Testing (RDT) for Treatment of Staphylococcus aureus Bloodstream Infections in Pediatric Patients,
Role: PI,
LLU Dept. of Pharmacy Practice,
(10/2023)
Status: Approved
Impact of Verigene and 24/7 Pharmacist-driven Interventions of Rapid Diagnostic Testing for Treatment of Gram-negative Bloodstream Infections in Pediatric Patients (VERI-24/7 GNB PEDS),
Role: PI,
LLU Dept. of Pharmacy Practice,
(11/2022)
Status: Approved
Assessment of nafcillin-associated phlebitis in pediatric patients,
Role: PI,
LLU Dept. of Pharmacy Practice,
(09/2021)
Status: Approved
Clinical Outcomes in Patients Prescribed Antibiotics for Multisystem Inflammatory Syndrome in Children (MIS-C),
Role: PI,
LLU Dept. of Pharmacy Practice,
(09/2021)
Status: Approved
Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19 Infection: An Institutional Experience,
Role: Investigator,
LLU Dept. of Pediatrics,
(03/2021)
Status: Approved
High risk Kawasaki disease case series,
Role: Investigator,
LLU Dept. of Pediatrics,
(12/2019)
Status: Approved
Single vs. combination anti-methicillin-resistant Staphylococcus aureus (Anti-MRSA) antibiotics for the treatment of complicated Pneumonia in pediatric patients: A retrospective analysis,
Role: PI,
LLU Dept. of Pharmacy Practice,
(11/2019 - 09/2024)
Status: Completed
Impact of Ceftazidime Duration on Neonatal Clinical Outcomes Across Various Weight Categories and Gestational Age,
Role: PI,
LLU Dept. of Pharmacy Practice,
(10/2024)
Status: Approved
Impact of Diagnostic Stewardship Using Microbial Cell-Free DNA Testing on Antimicrobial Utilization in Pediatric Patients,
Role: PI,
LLU Dept. of Pharmacy Practice,
(10/2024)
Status: Approved